Loading clinical trials...
Loading clinical trials...
Clinical Application Research on Differentiating Benign and Malignant Pulmonary Nodules Based on Multi-omics Detection Technology
Conditions
Interventions
PBMCS were isolated from the peripheral blood of hospitalized patients with pulmonary nodules and incubated with nanoparticles loaded with tumor antigens for a specific period of time to detect cancer
Locations
1
China
Soochow university
Suzhou, Jiangsu, China
Start Date
June 1, 2025
Primary Completion Date
June 1, 2026
Completion Date
June 1, 2026
Last Updated
July 2, 2025
NCT07510724
NCT07239063
NCT07393490
NCT07255950
NCT07231159
NCT07059923
Lead Sponsor
Zhao Jun
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions